Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, Pisa 56126, Italy.
Department of Medical, Surgical, Maternal, Pediatric and Adult Sciences, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena 41100, Italy.
Autoimmun Rev. 2016 Jul;15(7):747-51. doi: 10.1016/j.autrev.2016.03.012. Epub 2016 Mar 9.
No study has evaluated the incidence of new cases of thyroid autoimmunity (AT) and dysfunction (TD) in hepatitis C-associated mixed cryoglobulinemia (MC) patients. We aimed to evaluate the incidence of new cases of AT and TD in a wide group of MC patients vs. age- and gender-matched controls from the same geographic area. After exclusion of MC patients with TD at the initial evaluation, the appearance of new cases of TD was evaluated in 112 MC patients and 112 matched controls, with similar iodine intake (median follow-up 67months in MC vs. 78 in controls). A high incidence (P<0.05) of new cases of hypothyroidism, TD, anti-thyroperoxidase antibody (AbTPO) positivity, appearance of a hypoechoic thyroid pattern, and thyroid autoimmunity in MC patients vs. controls was shown. A logistic regression analysis showed that in MC, the appearance of hypothyroidism was related to female gender, a borderline high initial thyroid-stimulating hormone (TSH), AbTPO positivity, a hypoechoic, and small thyroid. In conclusion, we show a high incidence of new cases of AT and TD in MC patients. MC patients at high risk (female gender, a borderline high initial TSH, AbTPO positivity, a hypoechoic, and small thyroid) should have periodically thyroid function follow-up.
尚无研究评估丙型肝炎相关混合性冷球蛋白血症(MC)患者中新发甲状腺自身免疫(AT)和功能障碍(TD)的发生率。我们旨在评估广泛的 MC 患者中新发 AT 和 TD 的发生率与同一地理区域年龄和性别匹配的对照组相比。在排除初始评估时患有 TD 的 MC 患者后,在 112 例 MC 患者和 112 例匹配对照者中评估了新发 TD 的病例,两组碘摄入量相似(MC 的中位随访时间为 67 个月,对照组为 78 个月)。与对照组相比,MC 患者中出现新的甲状腺功能减退症、TD、抗甲状腺过氧化物酶抗体(AbTPO)阳性、甲状腺回声减弱模式出现和甲状腺自身免疫的发生率较高(P<0.05)。逻辑回归分析显示,在 MC 中,甲状腺功能减退的出现与女性性别、初始甲状腺刺激激素(TSH)略高、AbTPO 阳性、甲状腺回声减弱和甲状腺较小有关。总之,我们显示 MC 患者中 AT 和 TD 的新发病例发生率较高。高风险(女性、略高初始 TSH、AbTPO 阳性、甲状腺回声减弱和较小的甲状腺)的 MC 患者应定期进行甲状腺功能随访。